{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:19:47Z","timestamp":1793254787130,"version":"4.5.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.cmi.2023.05.008","type":"journal-article","created":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T12:20:57Z","timestamp":1683894057000},"page":"1133-1138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Early switch from intravenous to oral antibiotic treatment in bone and joint infections"],"prefix":"10.1016","volume":"29","author":[{"given":"Parham","family":"Sendi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Lora-Tamayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas W.","family":"Cortes-Penfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilker","family":"U\u00e7kay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2023.05.008_bib1","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/1469-0691.12003","article-title":"Antimicrobial treatment concepts for orthopaedic device-related infection","volume":"18","author":"Sendi","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2023.05.008_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001825","article-title":"An unsupported preference for intravenous antibiotics","volume":"12","author":"Li","year":"2015","journal-title":"PLOS Med"},{"key":"10.1016\/j.cmi.2023.05.008_bib3","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/cid\/cir842","article-title":"Systemic antibiotic therapy for chronic osteomyelitis in adults","volume":"54","author":"Spellberg","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.05.008_bib4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1056\/NEJMoa1710926","article-title":"Oral versus intravenous antibiotics for bone and joint infection","volume":"380","author":"Li","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2023.05.008_bib5","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/jama.279.19.1537","article-title":"Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group","volume":"279","author":"Zimmerli","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2023.05.008_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.18773\/austprescr.2020.008","article-title":"Oral or intravenous antibiotics?","volume":"43","author":"McCarthy","year":"2020","journal-title":"Aust Prescr"},{"key":"10.1016\/j.cmi.2023.05.008_bib7","doi-asserted-by":"crossref","first-page":"ofaa068","DOI":"10.1093\/ofid\/ofaa068","article-title":"Clinical characteristics, etiology, and initial management strategy of newly diagnosed periprosthetic joint infection: a multicenter, prospective observational cohort study of 783 patients","volume":"7","author":"Manning","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2023.05.008_bib8","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/cid\/ciw098","article-title":"Optimal duration of antibiotic therapy in patients with hematogenous vertebral osteomyelitis at low risk and high risk of recurrence","volume":"62","author":"Park","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.05.008_bib9","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1111\/dom.13651","article-title":"Oral amoxicillin-clavulanate for treating diabetic foot infections","volume":"21","author":"Gariani","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.cmi.2023.05.008_bib10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijid.2022.03.049","article-title":"The impact of the length of total and intravenous systemic antibiotic therapy for the remission of diabetic foot infections","volume":"120","author":"Haug","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.cmi.2023.05.008_bib11","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1093\/cid\/civ482","article-title":"2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the diagnosis and treatment of native vertebral osteomyelitis in adults","volume":"61","author":"Berbari","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.05.008_bib12","first-page":"CD009061","article-title":"Systemic antibiotics for treating diabetic foot infections","volume":"2015","author":"Selva Olid","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cmi.2023.05.008_bib13","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1093\/cid\/cis346","article-title":"2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections","volume":"54","author":"Lipsky","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.05.008_bib14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/jac\/dkt374","article-title":"Oral antibiotic treatment of staphylococcal bone and joint infections in adults","volume":"69","author":"Kim","year":"2014","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2023.05.008_bib15","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.11321","article-title":"Use of novel strategies to develop guidelines for management of pyogenic osteomyelitis in adults: a Wiki guidelines group consensus statement","volume":"5","author":"Spellberg","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cmi.2023.05.008_bib16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2165\/00003088-200948020-00002","article-title":"Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations","volume":"48","author":"Landersdorfer","year":"2009","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.cmi.2023.05.008_bib17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijid.2019.02.005","article-title":"Antibiotic penetration into bone and joints: an updated review","volume":"81","author":"Thabit","year":"2019","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.cmi.2023.05.008_bib18","doi-asserted-by":"crossref","first-page":"e415","DOI":"10.1016\/j.ijid.2011.03.003","article-title":"Ceftriaxone bone penetration in patients with septic non-union of the tibia","volume":"15","author":"Garazzino","year":"2011","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.cmi.2023.05.008_bib19","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2165\/0003088-200847120-00004","article-title":"Glycopeptide bone penetration in patients with septic pseudoarthrosis of the tibia","volume":"47","author":"Garazzino","year":"2008","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.cmi.2023.05.008_bib20","article-title":"Acidic pH environment induces autophagy in osteoblasts","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.cmi.2023.05.008_bib21","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/jac\/dkl489","article-title":"Combined effect of pH and concentration on the activities of gentamicin and oxacillin against Staphylococcus aureus in pharmacodynamic models of extracellular and intracellular infections","volume":"59","author":"Baudoux","year":"2007","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2023.05.008_bib22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/jac\/dkm476","article-title":"Tissue concentrations: do we ever learn?","volume":"61","author":"Mouton","year":"2008","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2023.05.008_bib23","series-title":"Antibiotics in laboratory medicine","first-page":"719","article-title":"Extravascular antimicrobial distribution and the respective blood and urine concentrations in humans","author":"Bamberger","year":"2005"},{"key":"10.1016\/j.cmi.2023.05.008_bib24","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1128\/AAC.12.4.548","article-title":"Gentamicin and tobramycin penetration into synovial fluid","volume":"12","author":"Dee","year":"1977","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2023.05.008_bib25","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/00003086-197810000-00047","article-title":"Antibiotic penetration of synovial fluid in infected and normal knee joints","volume":"136","author":"Schurman","year":"1978","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.cmi.2023.05.008_bib26","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1136\/annrheumdis-2019-215116","article-title":"Two weeks versus four weeks of antibiotic therapy after surgical drainage for native joint bacterial arthritis: a prospective, randomised, non-inferiority trial","volume":"78","author":"Gjika","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cmi.2023.05.008_bib27","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.cmi.2023.04.009","article-title":"Clinical pharmacological considerations in an early intravenous to oral antibiotic switch: are barriers real or simply perceived?","volume":"29","author":"Landersdorfer","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2023.05.008_bib28","doi-asserted-by":"crossref","first-page":"272","DOI":"10.7326\/0003-4819-120-4-199402150-00003","article-title":"Decrease in nosocomial Clostridium difficile-associated diarrhea by restricting clindamycin use","volume":"120","author":"Pear","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cmi.2023.05.008_bib29","doi-asserted-by":"crossref","first-page":"989","DOI":"10.7326\/0003-4819-128-12_Part_1-199806150-00005","article-title":"Hospital-wide restriction of clindamycin: effect on the incidence of Clostridium difficile-associated diarrhea and cost","volume":"128","author":"Climo","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cmi.2023.05.008_bib30","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/cid\/ciab426","article-title":"If, when, and how to use rifampin in acute staphylococcal periprosthetic joint infections, a multicentre observational study","volume":"73","author":"Beldman","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.05.008_bib31","doi-asserted-by":"crossref","first-page":"962","DOI":"10.3109\/00365548.2011.608082","article-title":"Efficacy of a combined oral clindamycin?rifampicin regimen for therapy of staphylococcal osteoarticular infections","volume":"43","author":"Czekaj","year":"2011","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.cmi.2023.05.008_bib32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/s12879-017-2429-2","article-title":"Clindamycin-rifampin combination therapy for staphylococcal periprosthetic joint infections: a retrospective observational study","volume":"17","author":"Leijtens","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2023.05.008_bib33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.anaerobe.2018.01.011","article-title":"Clostridioides (Clostridium) difficile infection in hospitalized patients with antibiotic-associated diarrhea: a systematic review and meta-analysis","volume":"50","author":"Nasiri","year":"2018","journal-title":"Anaerobe"},{"key":"10.1016\/j.cmi.2023.05.008_bib34","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/cid\/cir301","article-title":"Cumulative antibiotic exposures over time and the risk of clostridium difficile infection","volume":"53","author":"Stevens","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.05.008_bib35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/jac\/47.1.43","article-title":"Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study","volume":"47","author":"Wistr\u00f6m","year":"2001","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2023.05.008_bib36","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1017\/S0950268816000200","article-title":"Antibiotic-associated diarrhoea in emergency department observation unit patients","volume":"144","author":"Haran","year":"2016","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.cmi.2023.05.008_bib37","first-page":"433","article-title":"Epidemiology of adverse events and Clostridium difficile-associated diarrhea during long-term antibiotic therapy for osteoarticular infections","volume":"67","author":"Schindler","year":"2013","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cmi.2023.05.008_bib38","series-title":"FDA Drug Safety Podcast: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects","year":"2022"},{"key":"10.1016\/j.cmi.2023.05.008_bib39","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/j.1469-0691.2010.03361.x","article-title":"Gram-negative prosthetic joint infection treated with debridement, prosthesis retention and antibiotic regimens including a fluoroquinolone","volume":"17","author":"Aboltins","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2023.05.008_bib40","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/1469-0691.12649","article-title":"Gram-negative prosthetic joint infection: outcome of a debridement, antibiotics and implant retention approach. A large multicentre study","volume":"20","author":"Rodr\u00edguez-Pardo","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2023.05.008_bib41","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/17453674.2015.1026756","article-title":"75% success rate after open debridement, exchange of tibial insert, and antibiotics in knee prosthetic joint infections","volume":"86","author":"Holmberg","year":"2015","journal-title":"Acta Orthop"},{"key":"10.1016\/j.cmi.2023.05.008_bib42","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cmi.2016.01.004","article-title":"Validation of a treatment algorithm for orthopaedic implant-related infections with device-retention-results from a prospective observational cohort study","volume":"22","author":"Tschudin-Sutter","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2023.05.008_bib43","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1007\/s00264-015-2819-2","article-title":"Predictors of treatment outcome in prosthetic joint infections treated with prosthesis retention","volume":"39","author":"Puhto","year":"2015","journal-title":"Int Orthop"},{"key":"10.1016\/j.cmi.2023.05.008_bib44","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.ajem.2014.07.015","article-title":"Factors influencing the development of antibiotic associated diarrhea in ED patients discharged home: risk of administering IV antibiotics","volume":"32","author":"Haran","year":"2014","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.cmi.2023.05.008_bib45","doi-asserted-by":"crossref","first-page":"ofaa178","DOI":"10.1093\/ofid\/ofaa178","article-title":"Which patients discharged to home-based outpatient parenteral antimicrobial therapy are at high risk of adverse outcomes?","volume":"7","author":"Keller","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2023.05.008_bib46","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s15010-019-01381-8","article-title":"OPAT in Switzerland: single-center experience of a model to treat complicated infections","volume":"48","author":"Erba","year":"2020","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2023.05.008_bib47","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1093\/jac\/dky224","article-title":"Efficacy and safety of continuous infusions with elastomeric pumps for outpatient parenteral antimicrobial therapy (OPAT): an observational study","volume":"73","author":"Voumard","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2023.05.008_bib48","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s10096-016-2606-z","article-title":"Setting up an outpatient parenteral antimicrobial therapy (OPAT) unit in Switzerland: review of the first 18 months of activity","volume":"35","author":"Gardiol","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2023.05.008_bib49","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijid.2022.02.056","article-title":"Implementation of a collaborated antimicrobial stewardship program and outpatient parenteral antimicrobial therapy (OPAT) unit-driven monoclonal antibody therapy program for COVID-19 at an NYC hospital","volume":"118","author":"Rodriguez","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.cmi.2023.05.008_bib50","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/jac\/dkac047","article-title":"Outpatient parenteral antimicrobial therapy (OPAT) in the UK: findings from the BSAC national outcomes registry (2015\u201319)","volume":"77","author":"Gilchrist","year":"2022","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2023.05.008_bib51","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s15010-020-01398-4","article-title":"Efficacy and safety of a Belgian tertiary care outpatient parenteral antimicrobial therapy (OPAT) program","volume":"48","author":"Quintens","year":"2020","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2023.05.008_bib52","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/phar.2099","article-title":"Antimicrobial agents and catheter complications in outpatient parenteral antimicrobial therapy","volume":"38","author":"Keller","year":"2018","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.cmi.2023.05.008_bib53","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.ajic.2019.05.031","article-title":"What do patients say about their experience with urinary catheters and peripherally inserted central catheters?","volume":"47","author":"Trautner","year":"2019","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.cmi.2023.05.008_bib54","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1542\/hpeds.2018-0193","article-title":"Economic burden of home antimicrobial therapy: OPAT versus oral therapy","volume":"9","author":"Krah","year":"2019","journal-title":"Hosp Pediatr"},{"key":"10.1016\/j.cmi.2023.05.008_bib55","doi-asserted-by":"crossref","first-page":"108","DOI":"10.12688\/wellcomeopenres.15314.3","article-title":"Cost-effectiveness of oral versus intravenous antibiotics (OVIVA) in patients with bone and joint infection: evidence from a non-inferiority trial","volume":"4","author":"McMeekin","year":"2019","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.cmi.2023.05.008_bib56","doi-asserted-by":"crossref","first-page":"e2582","DOI":"10.1093\/cid\/ciaa985","article-title":"Clinical experience of implementing oral versus intravenous antibiotics (OVIVA) in a specialist orthopedic hospital","volume":"73","author":"Azamgarhi","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.05.008_bib57","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1017\/ash.2021.250","article-title":"Implementation of a consensus protocol for antibiotic use for bone and joint infection to reduce unnecessary outpatient parenteral antimicrobial therapy: a quality improvement initiative","volume":"2","author":"Suzuki","year":"2022","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"10.1016\/j.cmi.2023.05.008_bib58","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1542\/hpeds.2018-0279","article-title":"To discharge or not to discharge on outpatient parenteral antimicrobial therapy: that is the question","volume":"9","author":"Markham","year":"2019","journal-title":"Hosp Pediatr"},{"key":"10.1016\/j.cmi.2023.05.008_bib59","doi-asserted-by":"crossref","first-page":"ofac450","DOI":"10.1093\/ofid\/ofac450","article-title":"Eligibility for and use of oral antimicrobial therapy among veterans with osteoarticular infections: a retrospective study across 8 medical centers","volume":"9","author":"Mareau","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2023.05.008_bib60","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/s12891-021-04191-y","article-title":"Effectiveness of early switching from intravenous to oral antibiotic therapy in Staphylococcus aureus prosthetic bone and joint or orthopedic metalware-associated infections","volume":"22","author":"Bcl\u00e9","year":"2021","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.cmi.2023.05.008_bib61","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s00264-011-1221-y","article-title":"Duration of post-surgical antibiotic therapy for adult chronic osteomyelitis: a single-centre experience","volume":"35","author":"Rod-Fleury","year":"2011","journal-title":"Int Orthop"},{"key":"10.1016\/j.cmi.2023.05.008_bib62","first-page":"125","article-title":"Six weeks of antibiotic treatment is sufficient following surgery for septic arthroplasty","volume":"61","author":"Bernard","year":"2010","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cmi.2023.05.008_bib63","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1007\/s11999-009-0808-8","article-title":"Oral antibiotics are effective for highly resistant hip arthroplasty infections","volume":"467","author":"Cordero-Ampuero","year":"2009","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.cmi.2023.05.008_bib64","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/17453670710014167","article-title":"Low relapse with oral antibiotics and two-stage exchange for late arthroplasty infections in 40 patients after 2-9 years","volume":"78","author":"Cordero-Ampuero","year":"2007","journal-title":"Acta Orthop"},{"key":"10.1016\/j.cmi.2023.05.008_bib65","doi-asserted-by":"crossref","first-page":"191","DOI":"10.5194\/jbji-7-191-2022","article-title":"Intravenous antibiotic duration in the treatment of prosthetic joint infection: systematic review and meta-analysis","volume":"7","author":"Bouji","year":"2022","journal-title":"J\u00a0Bone Jt Infect"},{"key":"10.1016\/j.cmi.2023.05.008_bib66","doi-asserted-by":"crossref","first-page":"249","DOI":"10.5194\/jbji-7-249-2022","article-title":"Early switch to oral antibiotic therapy for the treatment of patients with bacterial native vertebral osteomyelitis: a quaternary center experience, systematic review, and meta-analysis","volume":"7","author":"Passerini","year":"2022","journal-title":"J\u00a0Bone Jt Infect"},{"key":"10.1016\/j.cmi.2023.05.008_bib67","first-page":"CD004439","article-title":"Antibiotics for treating chronic osteomyelitis in adults","volume":"9","author":"Conterno","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cmi.2023.05.008_bib68","doi-asserted-by":"crossref","first-page":"ofac366","DOI":"10.1093\/ofid\/ofac366","article-title":"Oral versus standard antimicrobial treatment for pyogenic native vertebral osteomyelitis: a single-center, retrospective, propensity score-balanced analysis","volume":"9","author":"Marconi","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2023.05.008_bib69","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1111\/apa.14373","article-title":"Outpatients with acute osteoarticular infections had favourable outcomes when they received just oral antibiotics without intravenous antibiotics","volume":"107","author":"Alcobendas","year":"2018","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.cmi.2023.05.008_bib70","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(14)61233-2","article-title":"Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial","volume":"385","author":"Bernard","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2023.05.008_bib71","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa2020198","article-title":"Antibiotic therapy for 6 or 12 weeks for prosthetic joint infection","volume":"384","author":"Bernard","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2023.05.008_bib72","doi-asserted-by":"crossref","first-page":"e1539","DOI":"10.1093\/cid\/ciaa1758","article-title":"Three weeks versus six weeks of antibiotic therapy for diabetic foot osteomyelitis: a prospective, randomized, noninferiority pilot trial","volume":"73","author":"Gariani","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.05.008_bib73","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1093\/jac\/dkz202","article-title":"Four versus six weeks of antibiotic therapy for osteoarticular infections after implant removal: a randomized trial","volume":"74","author":"Benkabouche","year":"2019","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2023.05.008_bib74","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1128\/AAC.01504-08","article-title":"Long-term follow-up trial of oral rifampin-cotrimoxazole combination versus intravenous cloxacillin in treatment of chronic staphylococcal osteomyelitis","volume":"53","author":"Euba","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2023.05.008_bib75","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1086\/424506","article-title":"A\u00a0randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection","volume":"39","author":"Schrenzel","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.05.008_bib76","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.amjmed.2021.10.007","article-title":"Oral is the new IV. Challenging decades of blood and bone infection dogma: a systematic review","volume":"135","author":"Wald-Dickler","year":"2022","journal-title":"Am J Med"},{"key":"10.1016\/j.cmi.2023.05.008_bib77","first-page":"266","article-title":"Randomized trial of ciprofloxacin compared with other antimicrobial therapy in the treatment of osteomyelitis","volume":"82","author":"Greenberg","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.cmi.2023.05.008_bib78","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1128\/AAC.34.1.40","article-title":"Oral ciprofloxacin compared with parenteral antibiotics in the treatment of osteomyelitis","volume":"34","author":"Gentry","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2023.05.008_bib79","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1128\/AAC.35.3.538","article-title":"Ofloxacin versus parenteral therapy for chronic osteomyelitis","volume":"35","author":"Gentry","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2023.05.008_bib80","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2106\/00004623-199072010-00017","article-title":"Oral ciprofloxacin compared with standard parenteral antibiotic therapy for chronic osteomyelitis in adults","volume":"72","author":"Mader","year":"1990","journal-title":"J\u00a0Bone Jt Surg Am"},{"key":"10.1016\/j.cmi.2023.05.008_bib81","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1097\/INF.0b013e3181f55a89","article-title":"Short- versus long-term antimicrobial treatment for acute hematogenous osteomyelitis of childhood: prospective, randomized trial on 131 culture-positive cases","volume":"29","author":"Peltola","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.cmi.2023.05.008_bib82","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1086\/597582","article-title":"Prospective, randomized trial of 10 days versus 30 days of antimicrobial treatment, including a short-term course of parenteral therapy, for childhood septic arthritis","volume":"48","author":"Peltola","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.05.008_bib83","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1097\/00003246-200007000-00006","article-title":"Intestinal absorption in patients after cardiac surgery","volume":"28","author":"Berger","year":"2000","journal-title":"Crit Care Med"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X2300232X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X2300232X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:35:27Z","timestamp":1761118527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X2300232X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":83,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1198743X2300232X"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2023.05.008","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early switch from intravenous to oral antibiotic treatment in bone and joint infections","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2023.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}